THE INGREDIENT, IN FOCUS
A hormone fragment with its own evidence question.
AOD-9604 is a modified fragment related to the end region of human growth hormone. A fragment carries only part of a longer chain. Being related to a hormone does not establish that it has the same actions, clinical effects or safety profile.
The biology, in plain words.
AOD-9604 is a modified fragment related to the end region of human growth hormone. A fragment carries only part of a longer chain. Being related to a hormone does not establish that it has the same actions, clinical effects or safety profile.
A molecule’s role in a pathway is one part of the story. A useful medical claim must also show a meaningful result in people, with harms and follow-up reported. A change in a lab measurement does not automatically mean better health.
What the studies found.
FDA’s 2024 compounding-committee briefing examines AOD-9604-related bulk substances and the evidence available at that time. It raises separate questions about identity, quality, effectiveness and safety. A committee briefing is neither a finished-product approval nor proof of a weight-loss benefit.
Details that change the comparison.
Check whether a source means the free base, acetate or a different growth-hormone fragment. A seller may group these under a single category, while meaningful comparison needs the exact chemical form and a clear pack amount.
Compare the complete ingredient record and the actual pack size. If a form, amount or batch fact is missing, it remains unknown. A lower price is not proof of quality, and a price per mg is a pack comparison rather than a dose recommendation.
Sources behind this profile.
Sources checked . Written by GotPeptide. No independent clinician review.